In this edition, late-stage colorectal, breast cancer diagnoses increase after start of COVID-19 pandemic; chemicals found in hair products increase viability of breast cancer cells in Black women; continued CDK 4/6 inhibition after breast cancer progression may benefit some patients; and more.

Read the full coverage here:

Late-stage colorectal, breast cancer diagnoses increase after start of COVID-19 pandemic

Chemicals found in hair products increase viability of breast cancer cells in Black women

Continued CDK 4/6 inhibition after breast cancer progression may benefit some patients

Some older women with luminal A breast cancer can safely forgo radiotherapy, study shows

Sacituzumab govitecan significantly extends PFS in advanced breast cancer subset

References:

Zhou JZ, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2021.48581.

Trevino L, et al. RF22 | PMON05. Presented at: ENDO Annual Meeting; June 11-14, 2022; Atlanta (hybrid meeting).

Kalinsky K, et al. Abstract LBA1004. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.

Source: Whelan TJ, et al. Abstract LBA501. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.

Rugo HS, et al. Abstract LBA1001. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.